Forte Biosciences (FBRX) Current Assets (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Current Assets data on file, last reported at $65.1 million in Q1 2026.

• Current Assets for Q1 2026 came in at $65.1 million, up 38.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.1 million (up 38.07% YoY), and the FY2025 annual result was $80.6 million, up 31.37% from the prior year.
• Current Assets fell to $65.1 million in Q1 2026 per FBRX's latest filing, from $80.6 million in the prior quarter.
• Over five years, Current Assets peaked at $107.6 million in Q2 2025 and troughed at $17.7 million in Q3 2024.
• A 5-year average of $50.0 million and a median of $41.5 million in 2022 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets sank 62.49% in 2024, then jumped 440.03% in 2025.
• A 5-year view of Current Assets shows it stood at $41.5 million in 2022, then retreated by 7.67% to $38.3 million in 2023, then soared by 60.06% to $61.3 million in 2024, then surged by 31.37% to $80.6 million in 2025, then fell by 19.21% to $65.1 million in 2026.
• Business Quant data shows FBRX's Current Assets at $65.1 million in Q1 2026, $80.6 million in Q4 2025, and $95.4 million in Q3 2025.